Tularemia vaccine development: paralysis or progress?

R Sunagar, S Kumar, BJ Franz… - … development and therapy, 2016 - Taylor & Francis
Francisella tularensis (Ft) is a gram-negative intercellular pathogen and category A biothreat
agent. However, despite 15 years of strong government investment and intense research …

[HTML][HTML] Durable Immunity to Ricin Toxin Elicited by Intranasally Administered Monoclonal Antibody–Based Immune Complexes

LE Tolman, JL Yates, Y Rong… - …, 2022 - journals.aai.org
Inhalation of ricin toxin (RT) elicits profuse inflammation and cell death within the upper and
lower airways, ultimately culminating in acute respiratory distress syndrome. We previously …

[HTML][HTML] Murine macrophage TLR2-FcγR synergy via FcγR licensing of IL-6 cytokine mRNA ribosome binding and translation

D Hunt, LA Drake, JR Drake - PloS one, 2018 - journals.plos.org
Macrophages (MØs) are sentinels of the immune system that use pattern recognition
receptors such as Toll-like receptors (TLR) to detect invading pathogens and immune …

Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories

DL Saunders, BC Pierson, J Haller, S Norris… - medRxiv, 2023 - medrxiv.org
Background Tularemia is a bacterial disease caused by the intracellular bacterium
Francisella tularensis (F. tularensis or Ft). It has been weaponized historically by multiple …

[HTML][HTML] Isotype-specific outcomes in Fc gamma receptor targeting of PspA using fusion proteins as a vaccination strategy against Streptococcus pneumoniae infection

K Wiedinger, J McCauley, C Bitsaktsis - Vaccine, 2020 - Elsevier
Streptococcus pneumoniae (Spn) remains a considerable threat to public health despite the
availability of antibiotics and polysaccharide conjugate vaccines. The lack of mucosal …

[HTML][HTML] Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in healthy research laboratory workers

DL Saunders, BC Pierson, J Haller, S Norris… - Frontiers in …, 2024 - frontiersin.org
Background Tularemia is caused by the intracellular bacterium Francisella tularensis (Ft). It
was weaponized historically due to low infectious aerosol dose, high morbidity, and mortality …

Induction of Protective Immunity in the Respiratory Tract with Ricin Toxin Immune Complexes

LE Tolman - 2023 - search.proquest.com
Ricin toxin (RT) is generated in the seeds of Ricinus communis. The highly potent toxin is
comprised of two subunits, RTA and RTB. RT enters cells using RTB before RTA separates …

[图书][B] Engineering a Complement Receptor-Targeted Vaccine Platform Using Francisella tularensis as a Model

KM Tummillo - 2020 - search.proquest.com
Targeting of immunogens to be recognized by specific immune cells is a method of adjuvant-
free enhancement of vaccinations. In this work, we have targeted bacteria to complement …

The severity of cryptococcus neoformans infection in Fc gamma receptor IIb deficient mice

S Surawut - 2018 - digital.car.chula.ac.th
Cryptococcus neoformans, an encapsulated yeast commonly infecting the central nervous
system, refers to as cryptococcal meningitis or cryptococcosis is commonly found in …